CANADIAN MYELOMA RESEARCH GROUP

The Canadian Myeloma Research Group funds and coordinates research into multiple myeloma, a blood cancer affecting plasma cells. Based in Concord, the organization supports clinical trials, laboratory investigations, and translational research conducted by scientists and oncologists across Canada. Multiple myeloma remains incurable despite advances in treatment, and the group works to accelerate discoveries that could improve survival rates and quality of life for patients. The organization connects researchers, clinicians, and patients to share findings and identify promising avenues for new therapies. By directing donations toward rigorous scientific projects, the Canadian Myeloma Research Group aims to move closer to better outcomes for people living with this disease.